Search

Copyright of Giornale di Medicina Militare is the property of Difesa Servizi S.p.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Giornale di Medicina Militare is the property of Difesa Servizi S.p.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

In forensic medicine and aviation medicine, the CDT biomarker is used in compliance with all regulations aiming to ensure psychophysical integrity for the purposes of public safety. The Scientific Society of Laboratory Medicine (IFCC) has identified the CDT biomarker (CarbohydrateDeficient Transferrin) as an evaluative test for chronic alcohol abuse, standardising its reference range and methodological procedure. The tasks of the Institute of Aerospace Medicine include assistance to military personnel and aircrews in order to ensure their fitness for flight, for which an altered CDT IFCC dosage is cause for ineligibility and referral for examination, except in cases where correct measurement is not possible, as in the case of numerous gene variants. The study will consider personnel undergoing medical examination over a welldefined period of time in order to test the adoption of the new standardised IFCC system for CDT, evaluating its impact on individuals as well as its technical, biochemical and methodological aspects. [ABSTRACT FROM AUTHOR]

The task of Aerospace Medicine is to protect the health of pilots and the community as a whole. It does so by studying all the factors that may compromise such health and by implementing preventive actions. In 2016, the enzymatic assay of Glucose-6-phosphate dehydrogenase was added to the tests for the selection as military pilots. The aim of this article is to assess the impact of the enzyme assay test during the selection procedure. A study was conducted on the pathological correlation between flight activity and enzymopathy from both a pathophysiological and molecular point of view. At the same time, an epidemiological study of a sample population was conducted together with the testing method. [ABSTRACT FROM AUTHOR]